Article

Pharma USA 2023: IRA Impact on Patients

Kevin Hagan, president and CEO of the PAN Foundation, participated on the Pharma USA 2023 panel "Post-Inflation Reduction Act: The continued need for patient assistance." Here he speaks to Pharmaceutical Executive about the IRA's impact on Medicare patients' affordability.

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!
Related Videos
Related Content
EVERSANA and Waltz Health Unite to Address Drug Pricing and Access Issues
August 29th 2025

EVERSANA and Waltz Health Unite to Address Drug Pricing and Access Issues

Nicholas Saraceno, Editor
Cell and Gene Therapy Check-in 2024
August 29th 2025

Cell and Gene Therapy Check-in 2024

Miranda Schmalfuhs
Layoffs Continue Across Biotech Industry as More Companies Restructure and Reprioritize
August 29th 2025

Layoffs Continue Across Biotech Industry as More Companies Restructure and Reprioritize

Don Tracy, Associate Editor
Industry Outlook 2022
August 29th 2025

Industry Outlook 2022

Elaine Quilici Miranda Schmalfuhs
AbbVie Latest to Commit to New US Manufacturing Growth Projects, Committing $195 Million to Expand API Capabilities
August 29th 2025

AbbVie Latest to Commit to New US Manufacturing Growth Projects, Committing $195 Million to Expand API Capabilities

Don Tracy, Associate Editor
Bayer Layoffs Reach 12,000 in Ongoing $2.3 Billion Restructuring Plan
August 29th 2025

Bayer Layoffs Reach 12,000 in Ongoing $2.3 Billion Restructuring Plan

Don Tracy, Associate Editor